Evidence map›Paper›PMID 18973582›Full record

ArticleThe European journal of neuroscience2008

Hypocretin /orexin preferentially activates caudomedial ventral tegmental area dopamine neurons.

Nicole M Vittoz, Brooke Schmeichel, Craig W Berridge

Abstract read
In one paragraph

Article in The European journal of neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 107 citations in OpenAlex.

  1. Pooled it
  2. Hypothalamic control of arousal.Reviews in endocrine & metabolic disorders · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?Current topics in behavioral neurosciences · 2017
    Review
  17. Diversity of Dopaminergic Neural Circuits in Response to Drug Exposure.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Review
  18. Article
  19. Orexin Signaling in the VTA Gates Morphine-Induced Synaptic Plasticity.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nicole M VittozPsychology Department, University of Wisconsin, Madison, WI 53706, USA.
Brooke Schmeichel
Craig W Berridge
University of Wisconsin–Madison · US

Funding

AMPHETAMINE-LIKE STIMULANTS: NOREPINEPHRINE &BEHAVIORR01DA010681 · NIDA · UNIVERSITY OF WISCONSIN MADISON · PI BERRIDGE, CRAIG W · 1997 to 2005
$1.4M
SYNTHETIC STRATEGIES TOWARD THE ELUCIDATION OF CENTRAL MECHANISMS IN THE BEHAVIORZ01DA000389 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI NEWMAN, AMY HAUCK · 1996 to 2008
$1.3M
NEUROCHEMISTRY OF AMPHETAMINE INDUCED AROUSALK02DA000389 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI BERRIDGE, CRAIG W · 1999 to 2008
$1.1M
Neurobiology of Orexin/Hypocretin-Induced ArousalR01MH062359 · NIMH · UNIVERSITY OF WISCONSIN MADISON · PI BERRIDGE, CRAIG W · 2001 to 2004
$896k
Intramural NIH HHS Z01 DA000389NIDA NIH HHS DA10681NIDA NIH HHS K02 DA000389NIDA NIH HHS R01 DA010681NIMH NIH HHS MH62359NIMH NIH HHS R01 MH062359
6 · The paper itself

Abstract

The hypocretin/orexin (HCRT) neuropeptide system modulates behavioral state and state-dependent processes via actions on multiple neuromodulatory transmitter systems. Recent studies indicate that HCRT selectively increases dopamine (DA) neurotransmission within the prefrontal cortex (PFC) and the shell subregion of the nucleus accumbens (NAs), but not the core subregion of the nucleus accumbens (NAc). The circuitry underlying the differential actions of HCRT across distinct DA systems is unclear. The current study examined whether HCRT preferentially activates PFC- and NAs-projecting relative to NAc-projecting DA neurons within the VTA. One week after infusion of the retrograde tracer fluorogold (FG) into the medial PFC, NAc or NAs, animals received a ventricular infusion of HCRT-1. Subsequent analyses conducted across the rostral-caudal extent of the VTA determined the degree to which: (i) Fos-immunoreactivity (ir) was observed within tyrosine hydroxylase (TH)-ir neurons; (ii) TH-ir was observed within FG-ir neurons; and (iii) Fos-ir was observed within FG-ir neurons. HCRT significantly increased Fos-ir in VTA DA (TH-ir) neurons, primarily in a restricted population of small-to-medium-sized DA neurons located within the caudomedial VTA. Furthermore, within this region of the VTA, PFC- and NAs-projecting TH-ir neurons were more likely to contain Fos-ir than were NAc-projecting TH-ir neurons. These results provide novel evidence that HCRT selectively activates PFC- and NAs-projecting DA neurons within the VTA, and suggest a potential role for HCRT in PFC- and NAs-dependent cognitive and/or affective processes. Moreover, these and other observations suggest that the dysregulation of HCRT-DA interactions could contribute to cognitive/affective dysfunction associated with a variety of behavioral disorders.

Indexed as

AnimalsCognition DisordersDopamineImmunohistochemistryIntracellular Signaling Peptides and ProteinsMaleMood DisordersNeural PathwaysNeuronsNeuropeptidesNucleus AccumbensOrexinsProto-Oncogene Proteins c-fosRatsRats, Sprague-DawleyStaining and Labeling2-hydroxy-4,4'-diamidinostilbene, methanesulfonate saltDopamineIntracellular Signaling Peptides and ProteinsNeuropeptidesOrexinsProto-Oncogene Proteins c-fosStilbamidinesTyrosine 3-Monooxygenase

Identifiers

PMID18973582
PMCPMC3247915
OpenAlexW2015484182

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.